<DOC>
	<DOC>NCT00130793</DOC>
	<brief_summary>The purpose of this study is to determine whether the refrigerator-stable formulation of an investigational vaccine has a comparable immune response (the body's ability to protect against disease) and safety profile to that of the freezer-stable formulation of the vaccine.</brief_summary>
	<brief_title>A Study to Evaluate Safety, Tolerability, and Immunogenicity of an Investigational Zoster Vaccine In Subjects With a History of Varicella (Chickenpox)(V211-010)(COMPLETED)</brief_title>
	<detailed_description>The duration of treatment is 4 weeks.</detailed_description>
	<mesh_term>Herpes Zoster</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Individuals who are at least 50 years of age or older with a history of varicella (chicken pox) Prior history of herpes zoster (shingles) Prior receipt of varicella or zoster vaccine Immunosuppressed</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>